NCT02101853 2025-12-01Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic LeukemiaNational Cancer Institute (NCI)Phase 3 Active not recruiting669 enrolled 14 charts
NCT02538926 2018-11-14Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaUniversity of WashingtonPhase 2 Withdrawn